NEPZAN
10 MG · film-coated tablet · box of 7
OLANZAPINEReference dated : 2026-10-01. Confirm price and availability with a pharmacist.
Laboratory
AFRIC PHAR
What is this medicine?
French reference leaflet: OLANZAPINE CRISTERS PHARMA 10 mg, comprimé. Confirm indications in Morocco with a pharmacist.
OLANZAPINE CRISTERS PHARMA contains the active substance olanzapine. Olanzapine belongs to a family of medicines called antipsychotics and is used to treat the following pathologies: · schizophrenia, a disease accompanied by symptoms such as hearing, seeing or smelling things that do not exist, having erroneous beliefs, unusual suspicion and social withdrawal. People suffering from this disease may also feel depressed, anxious or tense. · moderate to severe manic episodes, characterized by a state of excitement or euphoria. It has been shown that olanzapine prevents the recurrence of these symptoms in patients with bipolar disorder who have already responded to treatment with olanzapine during a manic episode.
Full clinical reference
Additional sections are available in French. Read the original document; the information concerns the French reference product.
Uses
Adults
Olanzapine is indicated in the treatment of schizophrenia.
In patients who initially responded to treatment, olanzapine has demonstrated its efficacy in maintaining this clinical improvement over the long term.
Olanzapine is indicated in the treatment of moderate to severe manic episodes.
Olanzapine is indicated in the prevention of relapses in patients with bipolar disorder who have already responded to treatment with olanzapine during a manic episode (see section 5.1).
Driving
The effects on the ability to drive vehicles and use machines have not been studied. Due to the risk of somnolence and dizziness, patients should be warned of this risk when using machines, including driving motor vehicles.
Commercial status
AMM sans prix
Therapeutic class
PSYCHIATRIE
References and update dates
AMMPS — catalogue marocain officiel · 2026-10-01
Product and price referenceBase de données publique des médicaments (France) · 2026-09-29 · Licence Ouverte
Read medical referenceThis information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-10-01: Not available in the verified source
Reference price recorded since 2026-06-01: Not available in the verified source
Referenced presentations and strengths
Same ingredient, strength and form
This grouping does not establish interchangeability.
LOZYXA
10 MG · film-coated tablet · box of 30
271,00 MAD
LOZYXA
10 MG · film-coated tablet · box of 30
271,00 MAD
MEDIZAPIN
10 MG · film-coated tablet · box 30 tablets pellicule
527,00 MAD
MEDIZAPIN
10 MG · film-coated tablet · box 10 tablets pellicule
240,00 MAD
OLYNZA
10 MG · film-coated tablet · box of 30
272,00 MAD
XAUTIS
10 MG · film-coated tablet · box of 10
99,80 MAD
XAUTIS
10 MG · film-coated tablet · box of 30
262,00 MAD
ZYPREXA
10 MG · film-coated tablet · box 7 tablets
234,00 MAD
ZYPREXA
10 MG · film-coated tablet · box of 28
Not available in the verified source
ZYPREXA
10 MG · film-coated tablet · box of 56
Not available in the verified source
Other strengths and forms
Routes and instructions may differ.
- LOZYXA · 2.5 MG · film-coated tablet · box of 10 tablets pellicules
- LOZYXA · 5 MG · film-coated tablet · box of 10
- LOZYXA · 2.5 MG · film-coated tablet · box of 30 tablets pellicules
- LOZYXA · 5 MG · film-coated tablet · box of 30
- LOZYXA · 2.5 MG · film-coated tablet · box of 10
- LOZYXA · 2.5 MG · film-coated tablet · box of 30
- LOZYXA · 5 MG · film-coated tablet · box of 10
- LOZYXA · 5 MG · film-coated tablet · box of 30
- MARVIL · 5 MG · tablet · box 28 tablets
- MARVIL · 5 MG · tablet · box 28 tablets
- MARVIL · 10 MG · tablet · box 28 tablets
- MARVIL · 10 MG · tablet · box 28 tablets